Neurelis, Inc.

April is Occupational Therapy Month, so we’d like to acknowledge all OT professionals working to help people with #epilepsy and other neurological disorders with their everyday activities by inspiring hope and changing lives. Learn more https://lnkd.in/efDfXTRp #OTmonth

We are excited to announce the FDA approval of our immediate-use medication for treatment of episodes of frequent seizures in children with #epilepsy 2-5 years of age. Read our latest press release to learn more: https://lnkd.in/gDXEqPE2

Neurelis recently published a report describing the development of a self-management tool for individuals with #seizure clusters. Check out the full, peer-reviewed e-publication in the journal Epilepsy & Behavior here: https://lnkd.in/g9DfFSnY

During National Public Health Week, Neurelis joins in advocating for healthy communities. We extend gratitude to all public health practitioners for their dedication to advancing care and support for individuals with #epilepsy and other neurological disorders. Learn more https://nphw.org/ #NPHW

We look forward to joining the neurology community at the American Academy of Neurology Annual Meeting to discuss advances in treatment for neurological disorders. For more info on Neurelis’ presentations highlighting analyses of seizure treatment at #AANAM visit https://lnkd.in/gPyEhcj8

Congratulations to Julie Hauger, Senior Manager of Sales and Events at Neurelis, for being recognized as a 2025 Luminary with the Healthcare Businesswomen’s Association, a global nonprofit organization. This honor is awarded to women who serve as role models within their organizations and are active mentors to help advance other women’s careers. We thank Julie for sharing her talents with our team! #HBAimpact

Help yourself, your friends, coworkers, and loved ones #BePrepared to respond quickly and confidently in the event of a seizure episode. Create or update your Seizure Action Plan today with helpful resources from the Seizure Action Plan Coalition. Visit https://bit.ly/40KFr03

For people with #acuteagitation, a need exists for rapid, noninvasive, non-coercive treatment options for use both in and outside of a medical setting. Learn more about Neurelis’ studies characterizing the pharmacokinetics of an investigational intranasal spray in the The Journal of Clinical Psychiatry here: https://bit.ly/4kFkj3l

On Certified Nurses Day we thank all nursing professionals who support people with #epilepsy and their families. Thank you for your contributions to the epilepsy community! #CND2025

Would you benefit from knowing about #seizures and how to respond if someone has a seizure episode? Sign-up for on-demand seizure recognition and response training with Epilepsy Alliance America here: https://bit.ly/433JeY6